Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Medikaloka Hermina Tbk. (HEAL) vs Mandom Indonesia Tbk. (TCID) Price & Performance

Medikaloka Hermina Tbk.Trade
Mandom Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Medikaloka Hermina Tbk. vs Mandom Indonesia Tbk. — how do they compare? Medikaloka Hermina Tbk. trades at Rp710 (market cap 10.83T, 12.37M 24h volume), while Mandom Indonesia Tbk. trades at Rp2,690 (market cap 1.07T, 100 24h volume). The key difference: Medikaloka Hermina Tbk. is far larger — about 10.1× Mandom Indonesia Tbk.'s market cap, and Medikaloka Hermina Tbk. is more actively traded (12.37M versus 100). Which is the better fit depends on your goals.

HEALTCID
Market Cap
10.83T1.07T
Volume
12.37M100
Lot
123.75K1
Turnover
8.71B269K
Average Price
703.752,690
Value
8.71B269K
Indicative Equilibrium Price
710
Indicative Equilibrium Volume
1.97K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

HEAL
View details
TCID
View details

About Medikaloka Hermina Tbk.

PT Medikaloka Hermina Tbk (“the Company”) was established based on Notarial Deed of Imam Santoso, S.H., No. 5 dated May 7, 1999.

Read more on HEAL

About Mandom Indonesia Tbk.

PT. Mandom Indonesia Tbk (the Company), formely PT Tancho Indonesia Tbk was incorporated under the framework of the Foreign Capital Investment law dated November 5, 1969.The Company’s Articles of Association have been amended several times, including change of par value from Rp. 1000 to Rp. 500,- and change in name to PT Tancho Indonesia Tbk. Then increase in the authorized share capital to Rp 312 billion and issued and paid up capital to Rp. 78 billion. At an Extraordinary General Meeting of Share Holders dated November 2000, it was resolved to change the company’s name to PT Mandom Indonesia Tbk.The company is located in Jakarta and factories are located in Jakarta and Industrial Estate MM2100, Cibitung, West Java. The Company commenced commercial production in April 16, 1971.

Read more on TCID